The Alzheimer's Association has invested €10 million in the LSP Dementia Fund, a venture capital fund that invests in companies developing treatments for Alzheimer's and other neurodegenerative diseases. The fund has reached its hard cap of €260 million, exceeding its original target of €100 million.